Riley C, Roy B, Herrin J, Spatz E, Silvestri MT, Arora A, Kell KP, Rula EY, Krumholz HM
Dig Dis Sci (1993) 38:66573.10.1007/BF01316798 6 GutzwillerJPGokeBDreweJHildebrandPKettererSHandschinDet alGlucagon-like peptide-1: a potent regulator of food intake in humans
While these findings provide preliminary evidence of the potential benefit of semaglutide in CUD in real-world populations further preclinical studies are warranted to understand the underlying mechanism and randomized clinical trials are needed to support its use clinically for CUD
More importantly, early dosing can signal to your body that you need medication more frequently than intended, potentially disrupting the homeostasis your system has achieved
It is designed to stimulate the pituitary gland to produce and release more growth hormone